The UK may release a vaccine for coronavirus before it is fully licensed, according to official documents. This is due to changes to licensing rules which will come into effect once the Brexit transition period is over.
Currently, the responsibility for licensing a vaccine for use in the UK still rests with the European Medicines Agency, but once the Brexit transition period is over in January 2021, this will transfer to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
